Annals of the American Thoracic Society
Scope & Guideline
Advancing pulmonary health through innovative research.
Introduction
Aims and Scopes
- Pulmonary Diseases and Disorders:
The journal covers a wide range of topics related to various pulmonary conditions, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung diseases, and pulmonary hypertension, with an emphasis on both clinical and translational research. - Critical Care Medicine:
Research in this area includes studies on managing critically ill patients, with a focus on respiratory failure, mechanical ventilation, and the impact of critical illness on long-term outcomes. - Sleep Medicine:
The journal publishes work on sleep-disordered breathing, including obstructive sleep apnea, its impact on overall health, and treatment strategies. - Public Health and Environmental Impacts:
Research addressing the intersections of respiratory health with public health issues, such as air pollution, smoking cessation, and health disparities, is a significant focus. - Innovative Therapeutics:
The journal highlights studies on novel therapeutic approaches, including biologics and pharmacological treatments for various pulmonary conditions. - Multidisciplinary Approaches:
Research that involves collaborative efforts across specialties, including insights from epidemiology, genetics, and health services research, is emphasized to address complex pulmonary issues.
Trending and Emerging
- Impact of COVID-19 on Respiratory Health:
A significant surge in studies related to the long-term effects of COVID-19 on pulmonary health, including post-COVID syndrome and its management, reflects the ongoing repercussions of the pandemic on respiratory care. - Telemedicine and Remote Patient Monitoring:
The rise of telehealth practices, particularly post-COVID-19, is leading to an increase in research on the effectiveness and implementation of telemedicine in managing chronic respiratory conditions. - Health Disparities and Equity:
There is an increasing focus on health equity, particularly regarding race, socioeconomic status, and access to care, as well as the impact of social determinants of health on pulmonary outcomes. - Artificial Intelligence and Machine Learning Applications:
Emerging research is increasingly utilizing AI and machine learning to improve diagnostics, treatment strategies, and predictive modeling in respiratory diseases. - Environmental Health and Respiratory Disease:
A growing body of literature examines the effects of environmental factors, including air pollution and climate change, on respiratory health, emphasizing the need for interdisciplinary approaches. - Personalized Medicine in Pulmonary Care:
There is a notable trend towards personalized approaches in treatment, particularly in asthma and COPD management, involving genetic, phenotypic, and biomarker-driven strategies.
Declining or Waning
- Traditional Epidemiological Studies:
There has been a noticeable decrease in the publication of traditional epidemiological studies that do not incorporate newer methodologies or technologies, such as big data analytics or machine learning, which are increasingly in demand. - Basic Science Research:
Although foundational research remains important, there appears to be a waning interest in purely laboratory-based studies without direct clinical implications, as the focus shifts towards translational research with immediate applications in patient care. - Single-Disease Focus:
Research that concentrates on single diseases in isolation is becoming less common, with a broader trend towards studies that consider comorbid conditions and the interconnectedness of various pulmonary disorders. - Outdated Treatment Protocols:
As new guidelines and treatment modalities emerge, older treatment protocols and their efficacy are being phased out, leading to fewer studies focused on traditional management strategies. - Non-comprehensive Health Disparities Studies:
Research focusing solely on health disparities without integrating social determinants of health or systemic factors has seen a decline, as the field moves towards more holistic approaches.
Similar Journals
Therapeutic Advances in Respiratory Disease
Transforming Respiratory Medicine Through InnovationTherapeutic Advances in Respiratory Disease is a prestigious open-access journal published by SAGE Publications Ltd, based in the United Kingdom. Since its inception in 2007, it has established itself as a leading platform for the dissemination of cutting-edge research in the fields of pulmonary and respiratory medicine and pharmacology. With an impressive impact factor and ranking—showing it is in the Q1 quartile in both Pharmacology (medical) and Pulmonary and Respiratory Medicine as of 2023—the journal's commitment to high-quality research is evident. In 2023, it ranks #32 out of 155 in Pulmonary and Respiratory Medicine and #57 out of 272 in Medical Pharmacology, positioning it in the 79th percentile across these disciplines. Open access since 2018, the journal ensures that its valuable content is readily accessible to a global audience of researchers, healthcare professionals, and students, facilitating the rapid exchange of knowledge that is crucial in the ever-evolving landscape of respiratory health. The journal's objectives include advancing understanding of respiratory diseases through innovative research and promoting the development of therapeutic strategies that improve patient outcomes, making it an essential resource for those dedicated to respiratory medicine.
BMC Pulmonary Medicine
Championing unrestricted access to vital pulmonary research.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.
BMJ Open Respiratory Research
Empowering knowledge exchange in pulmonary medicine.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
Egyptian Journal of Bronchology
Championing accessible research for respiratory innovation.Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.
Respiratory Investigation
Advancing knowledge in Pulmonary and Respiratory Medicine.Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.
THORAX
Exploring the frontiers of respiratory medicine.THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.
Jornal Brasileiro de Pneumologia
Fostering collaboration in the pursuit of better lung health.Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Innovating the future of respiratory physiology.AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.
Zeitschrift fur Pneumologie
Empowering Knowledge for Better Respiratory CareZeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.
Indian Journal of Respiratory Care
Elevating Standards in Pulmonary MedicineWelcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.